31
Views
2
CrossRef citations to date
0
Altmetric
Review

The treatment of female stress urinary incontinence: an evidenced-based review

&
Pages 109-120 | Published online: 17 Jun 2011

References

  • Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29:4–20.
  • Berghmans L, Hendriks H. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol. 1998;82:181–191.
  • Rapp D, Kobashi K. Outcomes following sling surgery: importance of definition of success. J Urol. 2008;180:998–1002.
  • Wilson P. Adult Conservative Management. Health Publications. 2005;11:869–883.
  • Gormely E. Biofeedback and behavioral therapy for the management of stress urinary incontinence. Urol Clin North Am. 2002;29:551–557.
  • Subak L, Wing R, West D, Franklin F. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360:481–490.
  • Wing R, Smith D, Grady D, Creasman J, Richter H, Myers D. Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months. J Urol. 2010;184:1005–1010.
  • Subak L, Richter H, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182:S2–S7.
  • Cannon T, Chancellor M. Pharmacotherapy for stress urinary incontinence. Rev Urol. 2003;5:135–141.
  • Thor K, Katofiasc M. Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat. J Pharmacol Exp Ther. 1995;274:1014.
  • Dmochowski R, Miklos J, Norton P, Zinner N, Yalcin I, Bump R. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol. 2003;170:1259–1263.
  • Millard R, Moore K, Rencken R, et al. Duloxetine versus placebo in the treatment of stress urinary incontinence: A four continent randomized clinical trial. Br J Urol Int. 2004;93:311–318.
  • Corcos J, Collet JP, Shapiro S, et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology. 2005;65:898–904.
  • Klarskov N, Lose G. Urethral injection therapy: what is the mechanism of action? Neurourol Urodyn. 2008;27:789–792.
  • Bent AE, Foote J, Siegel S, Faerber G, Chao R, Gormley EA. Collagen implant for treating stress urinary incontinence in women with urethral hypermobility. J Urol. 2001;166:1354–1357.
  • TerMeulen PH, Berghmans LC, Nieman FH, van Kerrebroeck PE. Effects of Macroplastique implantation system for stress urinary incontinence and urethral hypermobility in women. Int Urogynecol J Pelvic Floor Dysfunct. 2009;2:177–183.
  • Maher CF, O’Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG. 2005;112:797–801.
  • Malizia AAJr, Reiman HM, Myers RP, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA. 1984;251:3277–3281.
  • Dmochowski R, Herschorn S, Corcos J. Multicenter randomized controlled study to evaluate Uryx® urethral bulking agents in treating female stress urinary incontinence. Proceedings International Continence Society (ICS) 2002 (Heidelberg, Germany):187.
  • Kumar D, Kaufman M, Dmochowski R. Case reports: Periurethral bulking agents and presumed urethral diverticula. Int Urogynecol J Pelvic Floor Dysfunction. 2011. [Epub ahead of print].
  • Hurtado E, McCrery R, Appell R. The safety and efficacy of ethylene vinyl alcohol copolymer as an intra-urethral bulking agent in women with intrinsic urethral deficiency. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:869–873.
  • Lightner DJ, Fox J, Klingele C. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Urology. 2010;75:1310–1314.
  • Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigencystoscopically. Urology. 2009;4:771–775.
  • Strasser H, Marksteiner R, Margreiter E, et al. Autologous myoblasts and fibroblasts versus collagen for treatment of stress urinary incontinence in women: a randomized controlled trial. Lancet. 2007;369:2179–2186.
  • Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized doubleblind controlled trial. J Urol. 2001;1:153–158.
  • Keegan PE, Atiemo K, Cody J, McClinton S, Pickard R. Periurethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2007;3:CD003881.
  • Ghoniem G, Corcos J, Comiter C, Bernhard P, Westney OL, Herschorn S. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009;181:204–210.
  • Mayer RD, Dmochowski RR, Appell RA, et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007;69:876–880.
  • Andersen RC. Long-term follow-up comparison of durasphere and contigen in the treatment of stress urinary incontinence. J Low Genit Tract Dis. 2002;6:239–243.
  • Koduri S, Goldberg RP, Kwon C, Dobrez DG, Sand PK. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:346–351.
  • Isom-Batz G, Zimmern PE. Collagen injection for female urinary incontinence after urethral or periurethral surgery. J Urol. 2009;181:701–704.
  • Lai HH, Hurtado EA, Appell RA. Large urethral prolapse formation after calcium hydroxylapatite (Coaptite) injection. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1315–1317.
  • Palma PC, Riccetto CL, Martins MH, et al. Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxy-lapatite for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:670–671.
  • terMeulen PH, Berghmans LC, van Kerrebroeck PE. Systematic review: efficacy of silicone microimplants (Macroplastique) therapy for stress urinary incontinence in adult women. Eur Urol. 2003;44:573–582.
  • Ghoniem G, Corcos J, Comiter C, Westney OL, Herschorn S. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol. 2010;183:1444–1449.
  • Bano F, Barrington JW, Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for uro-dynamic stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:147–150; discussion 150.
  • Lightner D, Calvosa C, Andersen R, et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology. 2001;58:12–15.
  • Appell RA, Dmochowski RR, Herschorn S. Urethral injections for female stress incontinence. BJU Int. 2006;98(Suppl 1):27–30; discussion 31.
  • Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol. 2001;166:1350–1353.
  • Madjar S, Sharma AK, Waltzer WC, Frischer Z, Secrest CL. Periurethral mass formations following bulking agent injection for the treatment of urinary incontinence. J Urol. 2006;175:1408–1410.
  • Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:881–883.
  • Rapp DE, Kobashi KC. Outcomes following sling surgery: importance of definition of success. J Urol. 2008;180:998–1002.
  • Albo ME, Richter HE, Brubaker L, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;24(356):2143–2155.
  • Ward K, Hilton P. United Kingdom and Ireland Tension-free Vaginal Tape Trial Group. Prospective multicentrerandomised trial of tensionfree vaginal tape and colposuspension as primary treatment for stress incontinence. BMJ. 2002;13(325):67.
  • Chartier-Kastler E, Van Kerrebroeck P, Olianas R, et al. Artificial urinary sphincter (AMS 800) implantation for women with intrinsic sphincter deficiency: a technique for insiders? BJU Int. 2011;107:1618–1626.
  • Glazener CM, Cooper K. Anterior vaginal repair for urinary incontinence in women. Cochrane Database Syst Rev. 2001;1: CD001755.
  • Glazener CM, Cooper K. Bladder neck needle suspension for urinary incontinence in women. Cochrane Database Syst Rev. 2004;2:CD003636.
  • Dean NM, Ellis G, Wilson PD, Herbison GP. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2006;3:CD002239.
  • Lapitan MC, Cody JD, Grant A. Open retropubiccolposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2009;2:CD002912.
  • Demirci F, Yucel O. Comparison of pubovaginal sling and burchcol-posuspension procedures in type I/II genuine stress incontinence. Arch Gynecol Obstet. 2001;265:190–194.
  • Nager CW, FitzGerald M, Kraus SR, et al. Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol. 2008;179:1470–1474.
  • Kenton K, Richter H, Litman H, et al. Risk factors associated with urge incontinence after continence surgery. J Urol. 2009;182:2805–2809.
  • Brubaker L, Chiang S, Zyczynski H, et al. The impact of stress incontinence surgery on female sexual function. Am J Obstet Gynecol. 2009;200:562.e1–562.e7.
  • Novara G, Artibani W, Barber MD, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58:218–238.
  • Brubaker L, Cundiff G, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354:1557–1566.
  • Rehman H, Bezerra CC, Bruschini H, Cody JD. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2011;1:CD001754.
  • Guerrero KL, Emery SJ, Wareham K, Ismail S, Watkins A, Lucas MG. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG. 2010;117:1493–1502.
  • Ozog Y, Konstantinovic M, Zheng F, et al. Porous acellular porcine dermal collagen implants to repair fascial defects in a rat model: biomechanical evaluation up to 180 days. Gyneco l Obstet Invest. 2009;68:205–212.
  • Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Sys Rev. 2009;4:CD006375.
  • Petros P, Ulmsten U. An integral theory of female urinary incontinence: experimental and clinical considerations. Acta Obstet Gynecol Scand. 1997;166:3–8.
  • Delorme E. Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women. Prog Urol. 2001;11:1306–1313.
  • DeLeval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol. 2003;44:724–730.
  • Liapis A, Bakas P, Creatsas G. Monarc vs. TVT-O for the treatment of primary stress incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunction. 2008;19:185–190.
  • Abdel-Fattah M, Ramsay I, Pringle S, Hardwick C, Ali H. Evaluation of transobturator tapes (E-TOT) study: randomized prospective singleblinded study comparing inside-out vsoutside-in transobturator tapes in management of urodynamic stress incontinence: short term outcomes. Eur J Obstet Gynecol Reprod Biol. 2010;149:106–111.
  • But I, Faganelji M. Complications and short term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:857–861.
  • Takeyama M, Fukumoto Y, Noma M, Yamamoto K, Yamanaka M, U esaka Y A prospective study about trans-obturator tape procedures with the tape from the Gynecare TVT device and a C-shaped tunneling device. Available at: http://www.urotoday.com. Accessed June 1, 2010.
  • Latthe P, Foon R, Toozs-Hobson P. Transobturator and Retropubic tape procedures in stress urinary incontinence: a systematic review and meta-analysis of effectiveness and complications. BJOG. 2007;114:522–531.
  • Sung V Schleinitz M, Rardin C, Ward R, Myers D. Comparison of retropubic vs transobturator approach to midurethral slings: a systematic review and meta-analysis. Am J Obstet Gynecol. 2009;21:342–347.68.
  • Araco F, Gravante G, Sorge R, et al. TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence. Int Urogynecol J. 2008;19:917–926.
  • Richter H, Albo M, Zyczynski H, et al. Retropubic versus tran-sobturatormidurethral slings for stress incontinence. N Engl JMed. 2010;362:2066–2076.
  • Schierlitz L, Dwyer L, Rosamilia A, et al. Effectiveness of tension-free vaginal tape compared with transobturator tape in women with stress urinary incontinence and intrinsic sphincter deficiency: a randomized controlled trial. Obstet Gynecol. 2008;112:1253–1261.
  • Kennelly M, Moore R, Nguyen J, Lukban J, Siegel S. Prospective evaluation of a single incision sling for stress urinary incontinence. J Urol. 2010;184:604–609.